{"schema_version":"1","generated_at":"2026-11-07T00:11:03.587Z","data_as_of":null,"url":"https://www.findmykol.com/kol/igor-makhlin","json_url":"https://www.findmykol.com/kol/igor-makhlin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"igor-makhlin","name":"Igor Makhlin","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Hospital of the University of Pennsylvania","institution_url":"https://www.findmykol.com/institution/university-of-pennsylvania","city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1457745689","orcid":"0000-0001-7374-7330","openalex":"A5013270754"},"summary":"Igor Makhlin is an Oncology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 34 publications with 474 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":34,"cited_by_count":474,"h_index":12,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":86134.7,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457745689"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":1700.45,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457745689"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":394.83,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457745689"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1457745689","source":"payments"},"prescribing":{"data_year":2023,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":92.8,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":80.4,"drugs":[{"name":"Letrozole","share_pct":69.1},{"name":"Exemestane","share_pct":17.1},{"name":"Anastrozole","share_pct":13.8}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":12.4,"drugs":[{"name":"Verzenio","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":7.2,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":7.2,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":17.3,"facility_pct":82.7},"source":"medicare"},"publications":{"total":34,"shown":5,"withheld":29,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract PS4-07-07: Factors associated with pCR and distant recurrence in patients with early-stage TNBC treated with KN522","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps4-07-07","status":"verified"},{"title":"Mutability Dependence of Breast Cancer Metastasis and Latency to Recurrence","year":2026,"journal":"Cancer Discovery","source_url":"https://doi.org/10.1158/2159-8290.cd-25-2090","status":"verified"},{"title":"The Role of Molecular Profiling in Achieving Guideline-Concordant Care—From Sequencing to Survival","year":2026,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.5596","status":"verified"},{"title":"Datopotamab Deruxtecan in Metastatic Triple-Negative Breast Cancer with Severe Hepatic Impairment: A Case Report","year":2026,"journal":"Research Square","source_url":"https://doi.org/10.21203/rs.3.rs-9557830/v1","status":"verified"},{"title":"Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial","year":2025,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-025-03877-3","status":"verified"}],"source":"works"},"similar":[{"name":"Mohamed Gad","slug":"mohamed-gad","institution":"Hospital of the University of Pennsylvania","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mohamed-gad","json_url":"https://www.findmykol.com/kol/mohamed-gad/profile.json"},{"name":"Trinity Bivalacqua","slug":"trinity-bivalacqua","institution":"Hospital of the University of Pennsylvania","specialty":"Urology","url":"https://www.findmykol.com/kol/trinity-bivalacqua","json_url":"https://www.findmykol.com/kol/trinity-bivalacqua/profile.json"},{"name":"Selina Luger","slug":"selina-luger","institution":"Hospital of the University of Pennsylvania","specialty":"Hematology","url":"https://www.findmykol.com/kol/selina-luger","json_url":"https://www.findmykol.com/kol/selina-luger/profile.json"},{"name":"Ian Frank","slug":"ian-frank","institution":"Hospital of the University of Pennsylvania","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/ian-frank","json_url":"https://www.findmykol.com/kol/ian-frank/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"publications":29}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}